Potential benefits of specific nutraceuticals in Parkinson’s disease model in rats

Parkinson’s disease (PD) is one of the most common neurodegenerative diseases, which comes in second place in terms of prevalence a er Alzheimer’s disease. The rate of incidence of PD increases with the advancement of age. Searching for nutraceuticals for the management of PD is a good approach since, so far, there is no e cient drug for such a disease. In addition, an interrelation of the immune system and iron status in PD is an important issue to be studied. In this context, a question arises: do the nutraceuticals that can improve the disease may also enhance the iron status?